Llwytho...

Study Sets Response Benchmarks for FLT3‐Inhibitor Sequencing in FLT3‐Mutated AML

A new study of sequential exposure to FLT3 inhibitors demonstrates the benefits of these therapies across multiple lines and treatment settings for patients with FLT3‐mutated acute myeloid leukemia.

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2020
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869113/
https://ncbi.nlm.nih.gov/pubmed/33368881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13648
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!